Schonfeld Strategic Advisors LLC Opgen Inc Transaction History

Schonfeld Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$2.18 - $3.58 $52,102 - $85,562	-23,900 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.95 - $2.8 $46,800 - $67,200	-24,000 Reduced 50.1%	23,900 $54,000
Q1 2021 May 17, 2021	BUY	$1.8 - $3.55 $86,220 - $170,045	47,900 New	47,900 $120,000
Q4 2020 Feb 16, 2021	SELL	$1.7 - $2.47 $91,800 - $133,380	-54,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.98 - $3.37 $106,920 - $181,980	54,000 New	54,000 $0

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $38.7M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.